Vanda Pharmaceuticals, Inc. (VNDA) is “One to Watch”
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) is a biopharmaceutical company focused on developing new medicines and using novel approaches to improve the lives of patients. The company’s specific focus is on developing and commercializing clinical-stage products for central nervous system disorders. Vanda retains exclusive worldwide commercial rights to two products in clinical development for various central nervous system disorders. The company’s lead product, iloperidone, which the Company intends to market under the tradename Fanapt, is being developed to treat adult patients with schizophrenia. Last month, Vanda announced that the U.S. Food and Drug Administration (FDA) granted marketing approval of Fanapt. Unlike…